U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07065617) titled 'A Study to Test How BI 1819479 is Taken up and Processed by the Body' on July 04.
Brief Summary: This trial is intended to investigate the mass balance, metabolism, and basic pharmacokinetics of BI 1819479 (C-14) (Part A) and to investigate the absolute bioavailability of BI 1819479 (Part B) in healthy male volunteers.
Study Start Date: July 31
Study Type: INTERVENTIONAL
Condition:
Healthy
Intervention:
DRUG: [14C]BI 1819479
[14C]BI 1819479
DRUG: BI 1819479
BI 1819479
DRUG: BI 1819479 (C-14)
BI 1819479 mixed with [14C]BI 1819479
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Boehringer Ingelheim
Published by HT Digita...